Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting.
William David StrainPhil McEwanHeena HowittSimon MeadowcroftPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Takeda UK Ltd.